CN
Chandrahas Nadendla
About Chandrahas Nadendla
Data last updated:
Chandrahas Nadendla is a Director at Embiosys Diagnostics & Molecular Research Private Limited (since 2020) and Director at Nadendla Health Care Private Limited (since 2025). The companies operate in Healthcare. The largest current company by reported revenue is Embiosys Diagnostics & Molecular Research Private Limited at ₹79.9 Lakh (FY 2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Feb 2020 | 2013 | ₹79.9 Lakh (FY 2017) | Active | |
| Director | 28 Feb 2025 | 2025 | Active |
Board colleagues of Chandrahas Nadendla
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chandrahas Nadendla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chandrahas Nadendla
Chandrahas Nadendla currently holds 2 directorships: Embiosys Diagnostics & Molecular Research Private Limited (Director, since 11 Feb 2020, revenue ₹79.9 Lakh (FY 2017)); Nadendla Health Care Private Limited (Director, since 28 Feb 2025).
Chandrahas Nadendla was first appointed on 11 Feb 2020 as Director at Embiosys Diagnostics & Molecular Research Private Limited. The most recent appointment on record is 28 Feb 2025 at Nadendla Health Care Private Limited.
The current boards of Chandrahas Nadendla's companies include Dinakara Prasad Koganti (Embiosys Diagnostics & Molecular Research Private Limited), Jagarlamudi Sankara Rao (Embiosys Diagnostics & Molecular Research Private Limited), Kodanda Ramaiah Choudary Bodduluru (Embiosys Diagnostics & Molecular Research Private Limited), Kusumakumari Kanamarlapudi (Embiosys Diagnostics & Molecular Research Private Limited), Potini Subbaiah Venkata (Embiosys Diagnostics & Molecular Research Private Limited), Ramesh Choudary Puttagunta (Embiosys Diagnostics & Molecular Research Private Limited), among others.